B · Normal
[Animal experiments show that new antibodies can resist multiple human coronavirus infections] November 23rd, facing the continued threat of three highly pathogenic human coronaviruses: Severe Acute Respiratory Syndrome, COVID-19, and Middle East Respiratory Syndrome, scientists from Georgia State University and other institutions in the United States developed a new type of "bispecific nanobody." This broad-spectrum therapeutic not only effectively neutralizes the three viruses mentioned above, but also provides significant protection in mouse models. Relevant research was published in the "ACS Nano" magazine of the American Chemical Society.
Comments